She was noted to have left subclavian stenosis, with bilateral carotid stenosis of 60-81% also in [**9-4**].
Past Medical History: AS MR [**First Name (Titles) **] [**Last Name (Titles) **] Type II DM Hyperlipidemia PVD Asthma Chronic Bronchitis s/p CCY and hysterectomy  Social History: lives alone in apartment.
Pertinent Results: Cardiology Report ECHO Study Date of [**2138-2-19**]    PATIENT/TEST INFORMATION: Indication: Atrial fibrillation Height: (in) 63 Weight (lb): 145 BSA (m2): 1.69 m2 BP (mm Hg): 160/80 HR (bpm): 80 Status: Inpatient Date/Time: [**2138-2-19**] at 15:51 Test: TEE (Complete) Doppler: Full Doppler and color Doppler Contrast: None Tape Number: 2006W007-0:00 Test Location: West Cath/EP Lab Technical Quality: Adequate     REFERRING DOCTOR: DR. [**First Name8 (NamePattern2) 177**] [**Last Name (NamePattern1) **]  INTERPRETATION:  Findings:  LEFT ATRIUM: No spontaneous echo contrast or thrombus in the LA/LAA or the RA/RAA.
AORTIC VALVE: Bioprosthetic aortic valve prosthesis (AVR).
Medications and dosages are listed above (see Test Information section).
Local anesthesia was provided by benzocaine topical spray.
A bioprosthetic aortic valve prosthesis is present.
The aortic prosthesis leaflets appear to move normally.
DR. [**First Name (STitle) 7210**] [**Name (STitle) 7211**] [**Doctor Last Name 7205**] DR. [**First Name8 (NamePattern2) 7722**] [**Last Name (NamePattern1) 7723**]   Brief Hospital Course: Mrs. [**Known lastname 98282**] was admitted to the [**Hospital1 18**] on [**2138-2-4**] for further management of her occasional DOE.
Given the severity of her disease, the cardiac surgical service was consulted for surgical revascularization and valve repair.
An intraoperative transesophageal echocardiogram revealed severe aortic stenosis thus she underwent coronary artery bypass grafting to four vessels and an aortic valve replacement using a 21mm [**Last Name (un) **] [**Doctor Last Name **] pericardial model 2800 bioprosthesis.
Following surgery she continued to have signigicant chest tube output for which she was taken back to the OR for mediastinal exploration, coagulation of bleeders, and evacuation of clots.
She remained intubated until POD 6, she underwent bronchoscopy on POD 4 to evacuate her left main bronchus of thick secretions.
Beta blockade and aspirin were resumed.
It was determined that she could safely consume thin liquids and regular consistency.
Post operatively she developed atrial fibrillation for which she was placed on amiodarone and anticoagulation.
This progressively improved and was treated with po antibiotics, and dry sterile dressing changes.
On POD11 She had a Left pleural effusion and underwent left thoracentesis for approx.
On POD 16 she became hypotensive which failed to respond to fluid boluses.
She was transfused PRBC's, Platelets and given FFP.
Heparin and coumadin, and plavix were discontinued.
She was discharged to an extended care facility on POD 25  Medications on Admission: Verapamil 180' Zocor 10' Glipizide 10' metformin 500' Trusopt 2% OU one drop tid Xalatan one drop qhs ASA 325' Advair 250'' MVI   Discharge Medications: 1.
Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Furosemide 40 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) for 7 days: then re-evaluate need for diuretics.
Potassium Chloride 20 mEq Packet Sig: Two (2) Packet PO BID (2 times a day) for 7 days: continue if remains on diuretics.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours) as needed.
Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Amiodarone 200 mg Tablet Sig: One (1) Tablet PO BID (2 times a day): for 1 week, then decrease to 200 mg daily until discontinued by Dr. [**Last Name (STitle) 20222**].
Metformin 500 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Glipizide 5 mg Tab, Sust Release Osmotic Push Sig: One (1) Tab, Sust Release Osmotic Push PO DAILY (Daily).
Nystatin 100,000 unit/mL Suspension Sig: Five (5) ML PO QID (4 times a day) as needed.
Simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Latanoprost 0.005 % Drops Sig: One (1) Drop Ophthalmic  HS (at bedtime).
Dorzolamide 2 % Drops Sig: One (1) Drop Ophthalmic  TID (3 times a day).
Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig: One (1) Disk with Device Inhalation [**Hospital1 **] (2 times a day).
Ipratropium Bromide 17 mcg/Actuation Aerosol Sig: Two (2) Puff Inhalation Q4H (every 4 hours).
Albuterol 90 mcg/Actuation Aerosol Sig: 1-2 Puffs Inhalation Q6H (every 6 hours) as needed.
Glipizide 5 mg Tab, Sust Release Osmotic Push Sig: Two (2) Tab, Sust Release Osmotic Push PO DAILY (Daily).
Warfarin 1 mg Tablet Sig: Dosage will vary based on INR Tablet PO DAILY (Daily).
Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig: One (1) Disk with Device Inhalation [**Hospital1 **] (2 times a day).
Albuterol Sulfate 0.083 % Solution Sig: One (1)  Inhalation Q4H (every 4 hours) as needed.
Ipratropium Bromide 0.02 % Solution Sig: One (1)  Inhalation Q6H (every 6 hours) as needed.
Metformin 500 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Amiodarone 200 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily): take two pills daily for five days; then one pill daily thereafter.
Disp:*35 Tablet(s)* Refills:*2*   Discharge Disposition: Extended Care  Facility: [**Doctor Last Name **] [**Doctor Last Name **] hospital  Discharge Diagnosis: AS [**Doctor Last Name **] DM-2 [**Doctor Last Name **] PVD asthma   Discharge Condition: good   Discharge Instructions: may shower, no bathing or swimming for 1 month no creams, lotions or powders to any incisions no drivning for 1 month no lifting > 10# for 10 weeks  Followup Instructions: with Dr. [**First Name (STitle) 4640**] in [**1-3**] weeks with Dr. [**Last Name (STitle) 20222**] in [**1-3**] weeks with Dr. [**Last Name (STitle) 914**] in 4 weeks    Completed by:[**2138-3-3**
